Please Wait

Applying Filters...

Halotestin
CEP/COS
Table View

AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Halotestin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 2 USDMF, 1 CEP/COS, 2 NDC API, 2 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

11 FDF Dossiers, 11 FDA Orange Book

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 4 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 10 Kerry, 8 Microlex e.U, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 16 Disintegrants & Superdisintegrants, 16 Direct Compression, 12 Granulation, 11 Lubricants & Glidants, 10 Thickeners and Stabilizers, 9 Co-Processed Excipients, 7 Taste Masking, 5 Chewable & Orodispersible Aids, 5 Coating Systems & Additives, 5 Controlled & Modified Release, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Film Formers & Plasticizers, 1 Topical